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Abstract
Doppel protein (Dpl) is a paralog of the cellular form of the prion protein (PrPC), together sharing common structural and
biochemical properties. Unlike PrPC, which is abundantly expressed throughout the central nervous system (CNS), Dpl
protein expression is not detectable in the CNS. Interestingly, its ectopic expression in the brain elicits neurodegeneration in
transgenic mice. Here, by combining native isoelectric focusing plus non-denaturing polyacrylamide gel electrophoresis and
mass spectrometry analysis, we identified two Dpl binding partners: rat alpha-1-inhibitor-3 (a1I3) and, by sequence
homology, alpha-2-macroglobulin (a2M), two known plasma metalloproteinase inhibitors. Biochemical investigations
excluded the direct interaction of PrPC with either a1I3 or a2M. Nevertheless, enzyme-linked immunosorbent assays and
surface plasmon resonance experiments revealed a high affinity binding occurring between PrPC and Dpl. In light of these
findings, we suggest a mechanism for Dpl-induced neurodegeneration in mice expressing Dpl ectopically in the brain,
linked to a withdrawal of natural inhibitors of metalloproteinase such as a2M. Interestingly, a2M has been proven to be a
susceptibility factor in Alzheimer’s disease, and as our findings imply, it may also play a relevant role in other
neurodegenerative disorders, including prion diseases.
Citation: Benvegnu` S, Franciotta D, Sussman J, Bachi A, Zardini E, et al. (2009) Prion Protein Paralog Doppel Protein Interacts with Alpha-2-Macroglobulin: A
Plausible Mechanism for Doppel-Mediated Neurodegeneration. PLoS ONE 4(6): e5968. doi:10.1371/journal.pone.0005968
Editor: Petri Kursula, University of Oulu, Finland
Received December 31, 2008; Accepted May 8, 2009; Published June 18, 2009
Copyright:  2009 Benvegnu` et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grant HL-24066 from the National Heart, Lung, and Blood Institute to SP, by grant from Italian Institute of Technology -
SISSA Unit to SB and GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: legname@sissa.it
¤ Current address: ImClone Systems Incorporated, New York, New York, United States of America
Introduction
Prion diseases, generally known as transmissible spongiform
encephalopathies or TSE, are fatal neurodegenerative disorders
due to the conversion of the cellular form of the prion protein
(PrPC) into an abnormal, pathogenic and proteinase-resistant form
of the same protein (PrPSc). The family of prion diseases comprises
Creutzfeldt-Jakob disease (acronym CJD), fatal familial insomnia
(acronym FFI), and kuru in humans, chronic wasting disease
(acronym CWD), bovine spongiform encephalopathy (acronym
BSE), and scrapie in deer, cows and sheep, respectively. Once
PrPC is converted into its pathogenic isoform, PrPSc, it
accumulates in the brain, and its presence and accumulation is
linked to neurodegeneration in affected patients and animals [1,2].
In recent years, doppel protein (Dpl), a PrPC paralog, has been
identified as a protein sharing common biochemical and structural
properties with the latter [3,4,5]. Dpl and the C-terminal domain
of PrPC have only approximately 25% of primary aminoacidic
sequence identity (Figure 1C), yet their tertiary structure is very
similar (Figure 1B), and both share the same secondary structure
elements consisting of a three a-helix bundle with two short
b-strands (Figure 1A) [5]. Like PrPC, Dpl has two N-glycosylation
sites, and a highly enriched basic aminoacids flexible amino-
terminal region which likely contributes to its cellular trafficking
(Figure 1A). However, in contrast to PrPC, Dpl is expressed at very
low levels in the mouse central nervous system (CNS), whereas its
expression is high in non-nervous tissues, e.g. testes. Notably, two
transgenic (tg) mouse (Mo) lines ablated for the PrP gene develop
late-onset ataxia as well as Purkinje cells and granule cells
degeneration in the cerebellum [6,7]. In these tg lines, Dpl is
ectopically upregulated in the CNS. In contrast, other PrP-
knockout murine lines, in which Dpl ectopic expression in the
CNS is absent, do not develop either ataxia or neurodegeneration.
Furthermore, Dpl levels in the CNS proved to be inversely
correlated to the onset age of ataxic phenotype [8]. Interestingly,
tg mice expressing PrP with amino-proximal deletions (named
PrPDF) show ataxia and degeneration of the cerebellar granule cell
layer within a few weeks after birth [9]. PrPDF mutants lack
regions absent also in Dpl, therefore sharing structural properties
with the latter. Restoration of wild type PrP presence in the CNS
of mice expressing either Dpl [8] or PrPDF [9] rescues the ataxic
phenotype. These findings suggest that Dpl expression may lead to
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neurodegeneration similar to truncated PrP, and that the wild type
PrPC and Dpl may have opposite and antagonistic functions. In
fact, cell surface PrPC may have a protective role and antagonize
the toxic effect of Dpl in the CNS, either by interacting directly
with Dpl, or via another protein, or via non competitive
mechanisms [10]. Indeed, a neuroprotective function for PrPC
has been proposed [11,12,13].
In order to investigate the possibility that PrPC and Dpl may have
common binding partner(s), we previously described novel con-
structs of PrPC and Dpl fused to the Fc region of human IgG1, and
used these fusion proteins as probes to stain sections of mouse brain
[14]. We found restricted binding of both these fusion proteins to the
granule cell layer (GCL) of the cerebellum, indicating the presence of
ligands in this region that specifically bind to either PrPC or Dpl.
These findings prompt us to explore several biochemical routes to
identify physiological interacting molecules of PrPC and Dpl in the
cerebellum. However, while many physiological and putative PrP
interacting partners have been described (reviewed in [15]), very
little is known about Dpl-interacting proteins. We therefore focused
on the identification of Dpl binding proteins.
We utilized native isoelectric focusing (IEF) plus non-denaturing
polyacrylamide gel electrophoresis of rat cerebellum slices to
Figure 1. Mature PrP and Dpl protein share common structural architectures. (A) PrPC and Dpl have common secondary structure
elements, composed by three alpha helices (aA, aB and aC) and two beta strands (bA and bB). Both PrPC and Dpl have N-glycosylation sites (*),
disulfide bridges (S-S) and a GPI-moiety, which links the proteins to the extracellular side of the cellular membrane. PrPC and Dpl also share a
positively charged N-terminus. PrPC contains five octapeptide repeats capable of binding copper through histidine residues (modified from [52]). (B)
The topology of Dpl (PDB code: 1I17, left structure) is very similar to that of PrPC (PDB code: 1AG2, central structure). A significant difference is that aB
helix of Dpl (in green, right image) is bent and that the two beta strands are oriented differently than those in the PrPC (in orange, right image). (C)
Sequence alignment between mouse PrPC (mPrP, residues Val120–Arg229; SwissProt entry: P04925) and mouse Dpl (mDpl, residues Asn55–Gly155;
SwissProt entry: Q9QUG3) proteins. In this tract the two proteins share 18% of sequence identity and 44% of sequence similarity. Fully conserved
residues are highlighted in red, while semi-conserved are shown in blue.
doi:10.1371/journal.pone.0005968.g001
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extract and isolate the protein ligands of Dpl. These techniques
proved to be essential in our quest because they ensured that the
isolated proteins retained their native folding. By mass spectrom-
etry (MS) analysis, we demonstrated unequivocally that rat alpha-
1-inhibitor-3 (a1I3) is a major ligand for Dpl in the brain. Rat a1I3
is a member of the alpha-macroglobulin superfamily, which
contains both proteinases inhibitors and complement molecules
[16]. By homology search, we also identified mouse and human
alpha-2-macroglobulin (a2M) as Dpl interacting molecules.
Interestingly, PrPC was not found to interact to any alpha-2-
macroglobulins, suggesting that this class of proteins may not be
shared ligands for both PrPC and Dpl. Finally, in this study we also
demonstrate a strong interaction between PrP and Dpl, indicating
an intriguing plausible molecular mechanism for their biological
antagonism.
Materials and Methods
Animals
Animal husbandry was performed in compliance with the
European laws [European Community Council Directive, No-
vember 24, 1986 (86/609/EEC)], and in accordance to the
guidelines of the San Raffaele Hospital Institutional Animal Care
and Use Committee.
Proteins
Apo-transferrin, mouse albumin, aprotinin and alpha-chymo-
trypsin were purchased from Sigma-Aldrich (St. Louis, MO,
USA).
Recombinant mouse PrP and Mouse Dpl production and
purification
The production and purification of recombinant proteins are
described in Text S1.
Cloning and production of MoPrP-Fc and MoDpl-Fc
fusion proteins
MoPrP-Fc and MoDpl-Fc were produced as previously
described [14].
Extraction and identification of the protein from cerebellar
tissue with non-denaturing separation techniques
Analytical IEF. The technique for direct tissue isoelectric
focusing (IEF) has been previously described elsewhere [17]. For
brain tissue IEF, cerebella from Sprague-Dawley rats were taken,
immediately frozen in an isopentane-filled tube cooled in liquid
nitrogen, and stored at 280uC until use. Sections of 30 mm
thickness were cut on a cryostat microtome and, still frozen,
applied onto the hydrophilic side of a 1.0610.0 cm plastic support
(GelBond, FMC, Rockland, ME, USA) (Figure 2B-1 and
Figure 2B-2). The support was immediately placed upside down
onto an agarose gel plate for IEF (pH range, 3.0–10.0, Cambrex,
Rockland, ME, USA; IEF apparatus: Resolve Omega, Isolab Inc.,
Akron, OH, USA) and located both centrally and near the cathod.
A pH marker (IEF Standards, Bio-Rad, Hercules, CA, USA) was
electrophoresed at the two lateral sides of the plastic support.
Focusing was at 12 W, constant power, to a maximum of 700 V
for 2 h at 9uC. The plastic support and tissue sections were
removed after 30 min. At the end of the run, the gel was cut to
obtain a large central part, which was used for the preparative
procedure, and two small lateral parts, which included the two
lanes with pH marker, and the adjacent, 0.8 cm wide lanes where
the proteins had run. The lanes with pH marker were silver
stained [18]. The adjacent lanes were blotted onto nitrocellulose
[19]. Briefly, a sheet of nitrocellulose paper (Schleicher & Schuller,
Keene, NH, USA) was laid onto the gel, and covered with a PBS-
wetted sheet of fine filter paper, 8 sheets of absorbent paper, a glass
plate, and a weight of 0.5 kg for 1 h. Each of the following steps
was performed at 4uC, with gentle agitation, and alternated by
washing with PBS. The nitrocellulose was saturated in 10% bovine
serum albumin in PBS for 1 h. Incubated first with non-diluted
medium containing MoDpl-Fc (6 mL) overnight, then with a
biotinylated anti-human Fc antibody (Dako, Glostrup, Denmark)
at a dilution of 1:500 in 2% bovine serum albumin in PBS for 1 h.
The treated nitrocellulose was developed with avidin-biotin
(Vectastain ABC kit, Vector, Burlingame, CA, USA) and stained
with 0.5 mg/mL of diaminobenzidine in PBS and 0.02% of H2O2
up to visualize the band. The reaction was stopped with PBS.
Preparative IEF. The central part of the gel was used for
protein recovery (Figure 2B-2). Analytical IEF indicated the
position where the protein migrated in the gel (isoelectric point,
pI). To be sure of including the desired protein, an horizontal
piece of the gel, spanning 2 mm above and below protein’s
migration point, was removed from the support, and put into a
conical minitube in PBS (200 mL). After an overnight shaking at
4uC, the minitube was centrifuged at 7,0006g for 1 min. The
liquid, which contained the protein recognised by MoDpl-Fc, was
recovered (,100 mL), and concentrated (26) with a vacuum
desiccator. In the sample, the searched protein was mixed with
other proteins with similar, or slightly different pI. To obtain one
single-band protein, which was concentrated and suitable for mass
spectrometric (MS) identification, the sample was split into two
aliquots of 25 mL and run in electrophoresis on a non-denaturing
polyacrylamide gradient gel (4–15% acrylamide; Mini-Protean II;
Bio-Rad, Hercules, CA, USA) at 100 V for 3 h. One lane of the
gel was electrically blotted onto nitrocellulose paper (Mini Trans-
blot chamber, Bio-Rad, Hercules, CA, USA) in Tris/glycine
buffer at 200 mA for 3 h at 4uC. The nitrocellulose was then
treated as previously described after analytical IEF to confirm
binding specificity, and estimate the point of the protein migration.
This point was used to identify the protein in the second lane,
which was silver stained with a protocol suitable for MS
sequencing [20] (Figure 2C).
Protein identification by MALDI-TOF MS analysis
Gel bands were manually excised, reduced, alkylated and
digested overnight with bovine trypsin (Roche, Basel, Switzerland)
as described elsewhere [20]. One mL aliquots of the supernatant
were used for MS analysis on a MALDI-TOF Voyager-DE STR
(Applied Biosystems) mass spectrometer. Spectra were accumulat-
ed over a mass range of 750–4,000 Dalton (Da) with a mean
resolution of about 15,000. Spectra were internally calibrated
using trypsin autolysis products and processed via Data Explorer
software version 4.0.0.0 (Applied Biosystems). Alkylation of
cysteine by carbamidomethylation, and oxidation of methionine
were considered as fixed and variable modifications respectively.
Two missed cleavages per peptide were allowed, and a mass
tolerance of 50 ppm was used. Peptides with masses correspondent
to those of trypsin and matrix were excluded from the peak list.
Proteins were identified by searching against a comprehensive non
redundant protein database (NCBInr 20090222; Taxonomy:
Rodentia) using MASCOT algorithm [21].
Homology search
Initial sequence similarity searches were performed with
BLAST [22] using the a1I3 sequence as probe. All significant hits
returned are part of the proteinase-binding a-macroglobulins
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family. Sequence alignments were performed using ClustalW [23]
on a non-redundant set of the mammalian sequences from this
protein family. A similarity tree was generated using TreeView
[24].
Preparation of a1I3 and a2M
The protein a2M was purified to apparent homogeneity by
Zn2+-chelate chromatography, as previously described [25], with
minor modifications [26].
Rat a1I3 was purified to apparent homogeneity, as previously
described [26].
Enzyme-Linked ImmunoSorbent Assay (ELISA)
A general ELISA protocol was used with a1I3, a2M, MoDpl,
MoPrP, MoPrP-Fc, apo-transferrin, mouse albumin, aprotinin
and alpha-chymotrypsin. In detail, 96 well ELISA plates (Dynex
Corporation, Chantilly, VA, USA) coated with the various
proteins were used in biochemical assays for verification of
protein:protein interaction. A conventional ELISA procedure was
used with a slight modification [27]. For each well, stated amount
of protein was diluted in 100 mL of 0.1 M sodium bicarbonate
solution, pH 8.6 and incubated overnight at 4uC. After nine
washes with 16TBST, the well was blocked using saturating
solution [0.25% BSA, 0.05% Tween-20 in Dulbecco’s PBS Ca++
Mg++ Free (Gibco, Invitrogen, Carlsbad, CA, USA)] for 1 h at
room temperature (RT). The addition of proteins to the wells was
preceded by a pre-incubation in saturating solution at 4u C for 1 h.
All incubations for protein binding were performed at RT after
this step. In general, indicated amounts of PrP were diluted in
saturating solution and incubated for 2 h. Nine repeated washes
between incubations were performed with 16TBST. For PrP
detection, either 2 mg/mL of humanized anti-MoPrP HuM-D18
antibody fragments Fab [28] or a 1:500 dilution of a rabbit
polyclonal anti-MoPrP R073 [29] was added and incubated for
Figure 2. Identification of Dpl interacting protein in rat cerebellar slices. (A) Schematic representation of Dpl-Fc construct. Dpl protein is
fused with the Fc region of a human immunologlubulin IgG1. The resulting fusion protein is denominated Dpl-Fc. (B) Direct tissue isoelectric focusing
of solid tissues technique. This method allows the extraction of more numerous protein vs extracts of tissue homogenates [17]. The technique also
prevents the loss of conformational epitopes, which are denatured by standard extraction procedures. Cryostatic rat cerebellar slices (B-1) were put
onto the gel. After IEF run, two lateral parts of the gel were blotted onto nitrocellulose stripes, and tested with MoDpl-Fc, for the identification of the
binding protein (B-2). Arrows indicate the band (B-2 and B-3). Identification of the band’s approximate pI, deduced by comparison with the pH
marker, was 5.3. The central part of the gel was used for the protein recovery: a strip of the agarose gel (in white, B-2), which comprised the band
(arrows), was excised and placed inside a microtube in PBS. After incubation and centrifugation, the sample was run on native gradient PAGE (C). (C)
Gel electrophoresis of recovered protein. To yield amounts of the protein of interest suitable for proteomics, the sample obtained by isoelectric
focusing analysis was split into two aliquots and run on PAGE. One aliquot was transferred onto nitrocellulose paper and tested with MoDpl-Fc to
identify the protein of interest (C-1), the other one was silver stained (C-2). The arrow indicates the protein that binds to MoDpl-Fc, which was
eventually recognized to be rat a1I3 precursor.
doi:10.1371/journal.pone.0005968.g002
Dpl Interacts with a1I3 & a2M
PLoS ONE | www.plosone.org 4 June 2009 | Volume 4 | Issue 6 | e5968
1 h at RT. For Dpl detection, a 1:1,000 dilution of a rabbit
polyclonal anti-MoDpl was added and incubated for 1 h at RT
[8]. A 1 h incubation with 100 mL of goat anti-human Fab
(1:1,000 dilution) conjugated to alkaline phosphatase (Pierce,
Rockford, IL, USA) or 100 mL of an anti-rabbit IgG-Alkaline
Phosphatase 1:5,000 (Promega Corporation, Madison, WI, USA)
were added for 1 h at RT. MoPrP-Fc was detected using a goat
polyclonal anti-human Fc antibody at 1:1,000 ratio and incubated
for 1 h at RT.
Surface Plasmon Resonance
Surface Plasmon Resonance (SPR) analysis was performed at
20uC using the Biacore 2000 biosensor system (Biacore AB,
Uppsala, Sweden). For surface preparation, recDpl was immobi-
lized on a carboxymethyldextran (CM5; Biacore AB) sensor chip
using standard amine-coupling chemistry. EDC (N-ethyl-N’-
[32(dimethylamino)2propyl] carbodiimide) and NHS (N-hydro-
xysuccinimide) were used for surface activation and ligand
coupling; ethanolamine was used for deactivation. For kinetic
analysis, duplicate injections of analytes [recMoPrP(89–230) and
recMoPrP(23–230)] in various concentrations (0.44–4.4 mM) were
run under the buffer condition of HBS-N (10 mM HEPES,
150 mM NaCl), pH 7.4 (Biacore AB). Analytes were injected over
the Dpl-coupled and uncoupled surfaces in a CM5 sensor chip at a
flow rate of 20 mL/min for 2 min. Dissociation was monitored for
5 min. SPR from the uncoupled surface was used as a reference.
As many as four independent serial dilutions were carried out for
each binding experiment. The obtained kinetic data were analyzed
by BIAevaluation software (Biacore AB).
Statistical analyses
Results are given as mean6SD. Statistical analyses were
performed by using Student’s t test (two-tailed), and the null
hypothesis was rejected at the 0.05 level.
Results
MoPrP(23–230) and MoDpl(26–155) expression and
purification in E.coli
The production of pure and natively folded of either
recMoPrP(23–230) or recMoDpl(26–155) has been described in
[30] and [8], respectively.
MoPrP-Fc and MoDpl-Fc expression in the N2a cell line
MoPrP(23–231) andMoDpl(26–155) sequences were inserted into
an expression plasmid containing the Fc region of human IgG1 to
produce the MoPrP-Fc and MoDpl-Fc constructs, respectively.
The resulting plasmids were transfected independently in the
mouse neuroblastoma N2a cell line and the proteins were expressed
and secreted in the supernatant. Both MoPrP-Fc and MoDpl-Fc
were expressed at comparable levels as dimers as detected by
Western blot (data not shown), and used at concentration of 20 mg/
mL. The dimerization is conferred by the Fc portion and neither by
MoPrP nor MoDpl. A control Fc protein was also expressed and
successfully secreted in the supernatant of N2a cells (data not shown).
Further characterization of these constructs has been described in
detail elsewhere [14]. A schematic representation of Dpl-Fc
construct is shown in Figure 2A.
IEF of brain proteins and identification of a1I3 as Dpl-
interacting partner
After identifying the presence of MoDpl-Fc binders in the GCL
of the cerebellum of mice [14], we attempted to purify the specific
protein, or proteins, responsible for such positive reactivity. To this
purpose we employed rat cerebella. After extraction and
separation of native rat cerebellar proteins with IEF, we
transferred the protein to nitrocellulose support paper and used
MoDpl-Fc as probe. MoDpl-Fc proved to bind a sharp band at
pH 5.3 (Figure 2B-3). Subsequent preparative procedures (see
Materials and Methods) allowed us to obtain amounts of the
detected protein suitable for mass spectrometry analysis, which
identified the band as rat a1I3 (Figure 2C and Figure S1) (gi/
83816939, 29 matched peptides out of 39, sequence coverage
26%, Score: 231 Expect: 1.8e-018).
Identification of a2M by homology search
As a1I3 is a monomeric protein member of the alpha-
macroglobulin superfamily [31], we investigated the possibility
that Dpl could also interact with other members of the
macroglobulins family whose expression is not restricted to rat.
To assess this hypothesis, we performed a sequence homology
search analysis and identified also mouse and human a2M as
potential interacting partners of Dpl. Figure 3 shows a similarity
tree representing a multiple sequence alignment of a non-
redundant set of the mammalian sequences from the proteinase-
binding a-macroglobulins family of proteins, which are large
glycoproteins found on the plasma of vertebrates that can inhibit
proteinases from all catalytic classes by a molecular trapping
mechanism [32]. They contain a conserved thiolester motif that
allows rapid classification. In addition to the proteinase inhibitors,
the family also contains the complement components C3, C4 and
C5.
As shown in Figure 3, the members of the family showing the
strongest similarity to a1I3 are the a2M proteins, which prompted
experimental testing of such proteins as potential Dpl interacting
partners (see below).
ELISA validation of Dpl binding to a1I3
Dpl binding to a1I3 was investigated by ELISA. The assay was
performed using microtiter plates coated either with native
(NATIVE) or with methylamine-activated (FAST) form of a1I3,
and then incubated with the supernatant of respectively un-
trasfencted, mock-transfeted, and either MoPrP-Fc or MoDpl-Fc
transfected N2a cells. The results of this assay show a significant
binding signal for a1I3 by the conditioned medium of Dpl-Fc
transfected N2a cells (Figure 4).
Indeed, the ‘FAST’, activated form of a1I3 achieved a greater
binding signal to Dpl-Fc if compared to the signal obtained using
‘NATIVE’ a1I3.
On the contrary, a much weaker signal was detected for a1I3
incubated with the supernatant of PrP-Fc transfected cells, being
the former either in the native or in the activated form. Thus,
binding of a1I3 to PrP seems unlikely.
Confirmatory ELISA for a2M
After the identification of rat a1I3 by IEF and MS (see previous
sections), via bioinformatic analysis we also identified mouse and
human a2M as a potential Dpl-interacting partner. In order to
experimentally validate this hypothesis, a1I3 and a2M were coated
onto microtiter plates and subjected to ELISA, both in their
‘NATIVE’ form and in their activated form, and then incubated
with recDpl (see Materials and Methods).
As expected, the binding signal of a2M to recDpl was
comparable and generally equivalent to the one of a1I3. No
statistically different binding signals were achieved both by the
native and the activated forms of a1I3 and a2M (Figure 5). This
result seems contradictory with the results previously discussed, in
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which native and activated forms show different binding capability,
but this variation may be due to the differences between the
monomeric, unglycosylated, prokaryotic-produced recDpl and the
dimeric, glycosylated, eukaryotic-produced Dpl-Fc.
In addition, several proteins such as apo-transferrin, mouse
albumin, aprotinin and alpha-chymotrypsin were tested in ELISA
in order to validate the specificity of recDpl interaction with a2M.
In three independent experiments, no detectable recDpl binding
to either apo-transferrin, or mouse albumin, or aprotinin or alpha-
chymotrypsin was found (data not shown).
Saturation of binding of a2M by Dpl
In order to verify that the binding of a2M to Dpl was saturable,
we carried out a titration by means of ELISA. As shown in
Figure 6, the binding of Dpl (1.0 mg/well) can be saturated
applying increased concentrations of both native and activated
a2M (working range from 25 ng/well to 1.6 mg/well).
Measuring Dpl and PrP interaction
Although the molecular events underlying PrP-mediated rescue
of Dpl neurotoxicity are not well understood, one model suggested
for this interaction is the binding of PrP to Dpl. We performed
ELISA experiments to determine whether recPrP and recDpl bind
to each other. Indeed, recDpl bound to immobilized recPrP(23–
230) in a direct ELISA, detected using a rabbit polyclonal
antibody to Dpl (Figure 7A). Both recPrP(23–230) and recPrP(89–
230) bound to immobilized recDpl, as detected by a rabbit
polyclonal antibody to PrP (Figure 7B and Figure 7C). Full-length
recPrP(23–230) showed a greater binding capacity to Dpl
compared to recPrP(89–230), which lacks the octapeptide repeat
region. Moreover, a dimeric form of PrP expressed in N2a cells,
PrP-Fc [14], also bound to Dpl as effectively as monomeric, full-
length recPrP(23–230) (Figure 7D).
To understand the binding between Dpl and PrP molecules
further, we analyzed the kinetics of binding between these proteins
using Surface Plasmon Resonance (SPR) biosensor technology.
The binding data were analyzed by a mathematical calculation
based on the 1:1 (Langmuir) binding model (Table 1). This
simulation perfectly matched with our experimental data, which
demonstrated a 1:1 interaction between Dpl and both PrP(23–230)
and PrP(89–230). Similar to results revealed by the previously
performed ELISA, the binding capability of Dpl was greater with
full-length recPrP(23–230) than with recPrP(89–230) (Figure 8).
The KD of Dpl-PrP binding was,10 times smaller with full-length
PrP than with MoPrP(89–230) (Table 1). As suggested by kon and
koff constants of each binding, this was mainly due to the faster
association rate of recPrP(23–230) to Dpl compared to that of
recPrP(89–230); the dissociation rates did not differ greatly
(Figure 8 and Table 1).
Discussion
A major physiological function for PrPC is still elusive and it is
becoming increasingly clear that PrPC may play a pleiotropic role
in a variety of cellular functions. Studies have been conducted on
several strains of mice devoid of PrPC, but these animal models
have not been able to clarify PrPC actual functions. In fact, in
Figure 3. Similarity tree of a non-redundant set of the mammalian members of the a2M type of proteinase inhibitors. Except where
noted, the human sequences were taken for alignment purposes. The a2M and rat a1I3 families are respectively highlighted by right braces.
doi:10.1371/journal.pone.0005968.g003
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certain PrP-knockout mouse strains the PrPC paralog Dpl was
identified and emerged as a protein whose brain expression may
alter CNS functions. Indeed, neurodegeneration of Purkinje and
granule cells of the cerebellum occurs when Dpl is ectopically
expressed in the brain [3]. The level of expression of Dpl in the
brain is inversely correlated to the age at which Purkinje and
granule cells degeneration, as well as ataxic signs, start to be
observed. The concomitant expression of full-length PrP and Dpl
in tg mice is able to counteract the Dpl-induced ataxic phenotype,
suggesting that the expression of PrP can neutralize the toxic effect
of Dpl either by interacting directly with Dpl or through another
protein [8]. Hence, we endeavored to search for Dpl interacting
Figure 4. Dpl binds to a1I3. ELISA plates coated with a1I3 in its native (black bars) or activated, fast (white bars) forms were incubated with the
supernatant of respectively MoDpl-Fc transfected N2a cells (Dpl-Fc), MoPrP-Fc transfected N2a cells (PrP-Fc), mock-transfected N2a cells (Fc) and non-
transfected N2a cells (N2a). *, p,0.05. Data shown are representative of at least three independent experiments.
doi:10.1371/journal.pone.0005968.g004
Figure 5. ELISA binding measurements of recDpl with a2M and a1I3. Equimolar amounts of a2M and a1I3 were coated onto ELISA plates both
in their native and in their active form, and then incubated with recDpl. Primary antibody was used as control: black bars, a1I3; white bars, a2M. Data
shown are representative of at least three independent experiments.
doi:10.1371/journal.pone.0005968.g005
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Figure 6. Saturation curve for recDpl with increasing a2M concentrations. The working range of coated-a2M was from 25 ng to 1.6 mg/well.
recDpl was added 1.0 mg/well. A trend of linearity is observed for values up to 100 ng/well, whereas a trend of plateau can be found for values higher
than 400 ng/well. No difference is observed in the binding to recDpl comparing the native form with the activated form of a2M. y axis, OD values at
405 nm (x1,000); x axis, mg of proteins per well; white squares, a2M ‘‘fast’’ form; black rhombi, a2M ‘‘native’’ form.
doi:10.1371/journal.pone.0005968.g006
Figure 7. recDpl and recPrP bind to each other. To determine protein interaction, the primary protein was coated onto a 96-well plate then
incubated with the secondary protein. After washing, the presence of the secondary protein was detected by ELISA (Column 1). Control experiments
were performed without the primary protein (Column 2), secondary protein (Column 3), or primary antibody (Column 4). (A) Full-length recPrP(23–
230) coated onto the plate with recDpl as the secondary protein. Dpl binding was detected using a rabbit polyclonal antibody to Dpl. (B–D) recDpl
was coated onto ELISA plates and either recPrP(23–230) (B), recPrP(89–230) (C) or PrP-Fc (D) were incubated and measured for binding. PrP molecules
were detected using either a rabbit polyclonal antibody to PrP (B, C) or with an anti-human Fc secondary antibody (D). All ELISA measurements were
completed using an AP detection system at 405 nm. y axis, OD values at 405 nm (61,000). For all panels, graphs represent mean (bar) and standard
deviation (error bar) from measurements of at least three independent experiments.
doi:10.1371/journal.pone.0005968.g007
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protein(s) in the cerebellum, in order to better understand the role
of Dpl in cerebellar neurodegeneration. By using Dpl-Fc as a tool
to probe brain histoblots, we firstly identified a restricted
expression of Dpl binding partners in the granule cells of either
wild-type or PrPC-devoid mice [14]. Here, by combining IEF of
rat cerebellar proteins and mass spectrometry analysis, we
demonstrated for the first time the identification of rat a1I3 as
Dpl interacting partner in the cerebellum. Rat a1I3 is a plasma
proteinase inhibitor, which belongs to the superfamily of the
alpha-macroglobulin proteins (Text S2). We then performed
sequence homology analysis searches in order to find proteins
having high sequence homology with a1I3 not restrictedly
expressed in rat. We identified human a2M, a member of the
inhibitory macroglobulin family, and further confirmed the
binding of a2M to Dpl as well.
The inhibitory capacity of the alpha-macroglobulins resides in
their ability to entrap proteinase molecules and thereby hinder the
access of high molecular weight substrates to the proteinase active
site. This ability is thought to require at least two alpha-
macroglobulin subunits, yet the monomeric alpha-macroglobulin
rat a1I3 also inhibits proteinases [16]. Macroglobulins circulate in
blood as an inactive precursor, which is activated by a proteinase
after proteolytic attack on the so-called ‘‘bait region’’. Subse-
quently, thiol ester bonds present in each a2M subunit are
activated and generally the proteinase incorporates into the Glx
residue exposed by these events. The covalent binding by the
macroglobulin of the proteinase causes a conformational change in
the former which is responsible for the electrophoretic shift of the
activated form, thus referred to as ‘‘fast’’, if compared to the
inactive, ‘‘slow’’ form, or ‘‘native’’ form, of the macroglobulin.
The activation of the macroglobulin can also be achieved in vitro by
methylamine treatment. Activated forms of a2M are rapidly
removed from the circulation by cellular receptors, main example
of this is the low-density lipoprotein receptor-related protein
Figure 8. SPR sensorgram comparison of the kinetics of binding between Dpl with either recombinant full-length PrP (PrP(23–230))
or truncated PrP (PrP(89–230)). Equimolar amounts of PrP(23–230) and PrP(89–230) were injected over Dpl-coupled sensor chip, and kinetics of
binding was monitored as response units (RU, y axis) on time (seconds, x axis). Full-length PrP(23–230) proved to possess higher binding capability for
Dpl than truncated PrP(89–230). The sensorgrams in the figure were obtained with injection of 800 nM of both PrP(23–230) and PrP(89–230).
doi:10.1371/journal.pone.0005968.g008
Table 1. Kinetics analysis of interaction between PrP and Dpl
using SPR.
recPrP(89–230) recPrP(23–230)
kon (M
21s21) (8.460.02)6103 (1.260.08)6105
koff (s
21) (8.760.12)61024 (1.360.034)61023
KD (M) 1.0610
27 1.161028
doi:10.1371/journal.pone.0005968.t001
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(LRP), which recognizes the ‘‘fast’’ but not ‘‘slow’’ form of a2M
[16].
recDpl proved to bind a2M with generally the same apparent
affinity as for a1I3. To explore whether the binding of Dpl to a1I3
and a2M could be discriminative between the inactive and the
activated form of the proteins, binding assays were performed
using the two distinct biological forms. However, apparently
discordant data emerged in ELISA tests when using either recDpl
as antigen, or when using Dpl-Fc. There was no significant
difference in the binding of recDpl to both the inactive and the
activated form of a1I3 and a2M, whereas Dpl-Fc showed a
significant higher binding activity for the ‘‘fast’’ form of a1I3 in
contrast to the ‘‘native’’ form. However, while recDpl is bacteria-
produced in monomeric and unglycosylated form, Dpl-Fc is
produced by transfection of eukaryotic N2a cells and is secreted in
a dimeric and glycosilated form. Therefore, further investigations
are needed to clarify whether there could be any significant
difference in binding between Dpl and a1I3 and a2M in vivo.
Dpl shares common biochemical and structural features with
PrPC, i.e. it is a GPI-anchored protein, can bind divalent copper
ions, and folds in a PrPC-like tertiary structure [4,5]. Therefore, we
tested whether PrPC would also interact with a1I3 and a2M, but
this was not the case, as PrPC shows no binding signal when
compared to Dpl (Figure 4 and Figure 5).
These results suggest that macroglobulins may not be common
interacting partners both for PrP and Dpl. Differently from PrPC,
Dpl is not physiologically detectable in the adult mouse brain, and
the level of Dpl messenger RNA in the CNS is under strictly
regulated developmental control [33]. Thus, we suggest that Dpl
interaction with a1I3 and/or a2M may not be an usual
physiological feature in the brain. However, this interaction might
shed light on the role of Dpl on the cerebellar neurodegeneration
occurring in tg mice lines, such as Ngsk and Rcm0, which
ectopically overexpress Dpl in their CNS [3,6].
In light of our findings, we propose a novel possible mechanism
where Dpl-induced cerebellar neurodegeneration may be due to
withdrawal of natural inhibitor(s) of metalloproteinases, such as
a1I3 and a2M (Figure 9). The absence of neuropathological signs
in the cerebellum of both wild type (Figure 9A) and Prnp0/0 ZrchI
(Figure 9B) mice could be explained by a normal a2M activity not
compromised by the ineffective binding to PrP. When Dpl is
ectopically expressed in the CNS and PrP is simultaneously
knocked-out (Figure 9C), Dpl binding to a2M triggers the cerebellar
granule cells and Purkinje cells degeneration, finally leading to the
pathological ataxic phenotype. When Prnp0/0 tg mice ectopically
expressing Dpl in their CNS are backcrossed with full length PrP-
expressing mice, PrP co-expression rescues the ataxic phenotype
(Figure 9D), and this rescue is protein concentration dependent
Figure 9. Dpl-mediated model of cerebellar neurodegeneration. The model bears on the postulations as follows: (A) PrP and a2M do not
interact each other, therefore a2M is physiologically regulated in the cerebellum; (B) in Prnp
0/0 mice, a2M is still under physiological regulation as in
wild type situation; (C) in absence of PrP and in simultaneous presence of Dpl, a2M is sequestered and deregulated, thus leading to cerebellar
neurodegeneration. (D) PrP and Dpl are co-expressed, bind and antagonize each other depending on their stoichiometric ratio: on the left, PrP levels
are higher than Dpl, PrP sequesters the entire amount of Dpl and thus prevents Dpl interaction with a2M; on the right, Dpl expression is higher than
PrP, and residual amounts of Dpl unbound to PrP are still capable of binding a2M. (E) N-terminally truncated PrP binds with less affinity to Dpl, thus
permitting it to bind a2M. Mouse models are cited as follows: ZrchI Prnp
0/0 [53]; Edimburgh Prnp-/- [54]; Rcm0 Prnp0/0 [3]; ZrchII Prnp0/0 [55]; Ngsk
Prnp0/0 [6].
doi:10.1371/journal.pone.0005968.g009
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[8]. According to our results (Figure 7, Figure 8 and Tab. 1), full
length PrP can bind Dpl with high affinity. Thus, when expressed
at a higher level, PrP could sequester the total amount of Dpl,
prevent Dpl binding to a2M and inhibit Dpl-induced neurode-
generation (Figure 9D, left). On the contrary, when Dpl levels
exceed PrP expression, the remaining amount of Dpl unbound to
PrP is still capable of binding to a2M, and thus can elicit
neurodegeneration (Figure 9D, right).
Unlike full length PrP, N-terminally deleted PrP is incapable of
rescuing Dpl-induced degeneration [34].
Additionally, we show here SPR data indicating that truncated
PrP binds to Dpl with ten folds less affinity than full length PrP
(Figure 8 and Table 1). According to our model, N-terminally
truncated PrP binds Dpl with less efficacy than full length PrP,
even if over expressed. In this case, Dpl retains its capability of
binding to a2M and thus of triggering cerebellar degeneration
(Figure 9E).
It cannot be ruled out that PrP and Dpl may also exert
respectively protective and toxic functions on cerebellar neurons
through distinct, non competitive, signaling pathways, and that the
final cell fate might be the result of the sum of actions between
separate pathways. This in turn could explain why PrP mutants
like PrPDF show similar neurodegenerative phenotype in absence
of Dpl.
However, the broad biological significance of the binding
between Dpl and proteinases inhibitors needs to be further
investigated. At every instance, our results are the first ones
beginning to sort out a presumed physiological function of Dpl.
Dpl binding to proteinase inhibitors, in fact, might normally occur
in tissues with normal or higher level of Dpl expression, i.e. heart,
skeletal muscle, spleen and above all testes [33]. Notably, mice
devoid of Dpl are sterile. Their testes are macroscopically regular,
and discordant data have been reported from different groups
regarding motility and number of spermatozoa [35,36]. However,
the major cause of sterility is due to an impairment of the
spermatozoa in penetrating the egg’s zona pellucida [35], thus
suggesting an involvement of Dpl in correct spermatogenesis and
sperm-egg interaction. Indeed, members of a2M family are found
in the cytoplasm of Sertoli cells and in the tubular lumen and
interstitial tissue in the testes [37], suggesting the fact the a2M
could be a protective tool of the male reproductive system against
acrosomal proteinases released during sperm maturation process.
In addition, a2M family may play a role as a regulatory
component of cytokines, growth factors, hormones and proteinases
active during reproductive tissue remodeling and extracellular
matrix restructuration [38].
Hence, the interaction between Dpl and a2M would be
beneficial in testes where Dpl is physiologically highly expressed
and its expression proves to be necessary for correct spermatozoa
performance, while in the CNS, ectopic expression of Dpl in tg
mice, and possibly its interaction with a2M, is highly toxic to GCL
and Purkinje neurons. Thus, the same biological mechanism could
be beneficial in the male reproductive tissue while lethal in the
CNS.
a2M is a genetic risk factor for Alzheimer’s disease (AD)
[39,40,41,42]. Moreover, a2M was found to co-localize with beta-
amyloid (Ab) plaques in AD patients [43], and is supposed to
mediate the internalization and the clearance of a2M-Ab
complexes, possibly by interaction with one of its major neuronal
receptors, the low-density lipoprotein receptor-related protein
(LRP) [44,45,46,47,48]. Indeed, PrP internalization and trafficking
is also mediated by LRP [49,50]. This finding raises the question
whether a possible interaction of PrPC with LRP could have a key
role in the conversion of PrPC into PrPSc. Interestingly, a2M was
found to facilitate, at least in vitro, PrPC–PrPSc conversion [51]. In
light of our findings, albeit a2M was not found to directly interact
with PrPC, it cannot be ruled out that a2M activity could play a
role also in prion diseases and other neurodegenerative disorders
in addition to AD.
Supporting Information
Figure S1 MASCOT Search Result output. (A) List of the 29
peptides after MALDI-TOF MS analysis matching the query. (B)
Primary aminoacid sequence of rat a1I3. Matched peptides are
shown in red bold.
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Text S1 Recombinant mouse PrP and Dpl production and
purification
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